AKTIVITAS HESPERIDIN SEBAGAI AGEN KOKEMOTERAPI BERTARGET P-GLIKOPROTEIN DAN IKK UNTUK MENGATASI RESISTENSI PADA SEL MCF-7 RESISTEN DOKSORUBISIN
Doxorubicin is a chemotherapeutic agent used to treat breast cancer, but it induces resistance in some cancers especially in breast cancer. One of the doxorubicin resistance mechanism was resulted from Pgp overexpression, which is an energy dependent pump effluxing xenobiotics out from cells. This s...
| Hlavní autoři: | , |
|---|---|
| Médium: | Diplomová práce |
| Vydáno: |
[Yogyakarta] : Universitas Gadjah Mada
2012
|
| Témata: |